Cefrun S 500mg/250mg Injection
Marketer
Avonic Life Sciences
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefrun S 500mg/250mg Injection
Cefrun S 500mg/250mg injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administered solely under medical guidance, this medication necessitates adherence to the prescribed dosage schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (skin rashes, itching, swelling, breathing difficulty). Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration contribute to faster recovery. Your doctor may order tests to monitor the drug's impact.
Primary Ingredients of Cefrun S 500mg/250mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Cefrun S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefrun S 500mg/250mg Injection:
The medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Cefrun S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefrun S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefrun S 500mg/250mg Injection works:
Ceftriaxone and sulbactam, combined as Cefrun S 500mg/250mg Injection, offer targeted antibacterial action. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam's role as a beta-lactamase inhibitor counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concomitant alcohol ingestion and Cefrun S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
Cefrun S 500mg/250mg Injection is typically regarded as safe for use in pregnancy. Preclinical trials in animals have indicated minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Cefrun S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cefrun S 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefrun S 500mg/250mg Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Cefrun S 500mg/250mg, requires careful administration to patients exhibiting severe hepatic impairment. Dosage modification may be necessary for these individuals. Physician consultation is advised. Altering the Cefrun S 500mg/250mg injection dosage is not suggested for those with mild or moderate liver dysfunction.
What if you forget to take Cefrun S 500mg/250mg Injection :
Should you inadvertently skip a dose of Cefrun S 500mg/250mg Injection, seek medical advice.
Facts to Know About Cefrun S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently